Voyager Therapeutics, Inc. (VYGR)

PriceLoading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

12 annual periodsNewest to oldest
202520242023202220212020201920182017201620152014
Revenue$40.4M$80.0M$250.0M$40.9M$37.4M$171.1M$104.4M$7.6M$10.1M$14.2M$17.3M
Research & development$134.7M$127.4M$92.2M$60.8M$73.8M$108.8M$119.7M$64.9M$62.3M$42.2M$27.7M$8.9M
Operating expenses$172.2M$163.3M$128.0M$91.7M$111.0M$143.7M$156.1M$98.7M$82.0M$55.5M$37.6M$14.4M
Operating income−$131.8M−$83.3M$122.0M−$50.8M−$73.6M$27.4M−$51.7M−$91.1M−$71.9M−$41.3M−$20.3M−$14.4M
Net income−$119.7M−$65.0M$132.3M−$46.4M−$71.2M$36.7M−$43.6M−$88.3M−$70.7M−$40.2M−$29.7M−$16.3M
Basic EPSper diluted share-$2.04-$1.13$3.08-$1.21-$1.89$0.99-$1.21-$2.75-$2.64-$1.59$9.14$27.83
Diluted EPSper diluted share-$2.04-$1.13$2.97-$1.21-$1.89$0.98-$1.21-$2.75-$2.64-$1.59$9.14$27.83

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)26$799.6K disclosed value
26 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Apr 2, 2026Form 4 · 10b5-1Sandrock AlfredPresident and CEOSellCommon Stock11.5K$3.87$44.5K472.5K
Feb 24, 2026Form 4 · 10b5-1Swartz RobinCOO & CBOSellCommon Stock6.5K$3.77$24.3K199.7K
Feb 24, 2026Form 4 · 10b5-1Sandrock AlfredPresident and CEOSellCommon Stock14.2K$3.79$53.8K484.1K
Feb 24, 2026Form 4 · 10b5-1Jorgensen Nathan D.Chief Financial OfficerSellCommon Stock4.7K$3.77$17.6K151.4K
Feb 24, 2026Form 4 · 10b5-1Carter Todd AlfredChief Scientific OfficerSellCommon Stock4.2K$3.76$15.7K145.7K